[Bromocriptine in Parkinson's disease: pleuropulmonary toxicity]. 1985

J J Douvier, and J Vergeret, and A Taytard, and E Brottier, and P Domblides, and F Dubos, and P Freour

The authors report a case of pleuro-pulmonary fibrosis after 9 months of high dose bromocriptine therapy for the treatment of Parkinson's disease. When the drug was stopped there was a significant improvement of the clinical state with complete regression of chest pain and dyspnea of effort. The major inflammatory biological syndrome disappeared completely. Chest X-rays showed partial improvement with signs of pleural pneumonitis. The results of ventilatory and respiratory function tests stabilised. After one year follow-up, the causal relationship of this iatrogenic pathology has therefore been established. The initial diagnostic problems are stressed, particularly with respect to malignant disease (mesothelioma) when there has been exposure to asbestos, as in our case. The early stages must be carefully looked for so as to prevent fibrosing complications. The presence of immune complexes in our case could indicate immuno-allergic mechanism.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010300 Parkinson Disease A progressive, degenerative neurologic disease characterized by a TREMOR that is maximal at rest, retropulsion (i.e. a tendency to fall backwards), rigidity, stooped posture, slowness of voluntary movements, and a masklike facial expression. Pathologic features include loss of melanin containing neurons in the substantia nigra and other pigmented nuclei of the brainstem. LEWY BODIES are present in the substantia nigra and locus coeruleus but may also be found in a related condition (LEWY BODY DISEASE, DIFFUSE) characterized by dementia in combination with varying degrees of parkinsonism. (Adams et al., Principles of Neurology, 6th ed, p1059, pp1067-75) Idiopathic Parkinson Disease,Lewy Body Parkinson Disease,Paralysis Agitans,Primary Parkinsonism,Idiopathic Parkinson's Disease,Lewy Body Parkinson's Disease,Parkinson Disease, Idiopathic,Parkinson's Disease,Parkinson's Disease, Idiopathic,Parkinson's Disease, Lewy Body,Parkinsonism, Primary
D010995 Pleural Diseases Diseases involving the PLEURA. Disease, Pleural,Diseases, Pleural,Pleural Disease
D011658 Pulmonary Fibrosis A process in which normal lung tissues are progressively replaced by FIBROBLASTS and COLLAGEN causing an irreversible loss of the ability to transfer oxygen into the bloodstream via PULMONARY ALVEOLI. Patients show progressive DYSPNEA finally resulting in death. Alveolitis, Fibrosing,Idiopathic Diffuse Interstitial Pulmonary Fibrosis,Fibroses, Pulmonary,Fibrosis, Pulmonary,Pulmonary Fibroses,Alveolitides, Fibrosing,Fibrosing Alveolitides,Fibrosing Alveolitis
D001971 Bromocriptine A semisynthetic ergotamine alkaloid that is a dopamine D2 agonist. It suppresses prolactin secretion. 2-Bromoergocryptine,Bromocryptin,2-Bromo-alpha-ergocryptine,2-Bromo-alpha-ergokryptine,2-Bromoergocryptine Mesylate,2-Bromoergocryptine Methanesulfonate,2-Bromoergokryptine,Bromocriptin,Bromocriptine Mesylate,CB-154,Parlodel,2 Bromo alpha ergocryptine,2 Bromo alpha ergokryptine,2 Bromoergocryptine,2 Bromoergocryptine Mesylate,2 Bromoergocryptine Methanesulfonate,2 Bromoergokryptine,CB 154,CB154,Mesylate, 2-Bromoergocryptine,Mesylate, Bromocriptine,Methanesulfonate, 2-Bromoergocryptine
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

J J Douvier, and J Vergeret, and A Taytard, and E Brottier, and P Domblides, and F Dubos, and P Freour
October 1988, Archives of internal medicine,
J J Douvier, and J Vergeret, and A Taytard, and E Brottier, and P Domblides, and F Dubos, and P Freour
January 1990, Clinical and experimental neurology,
J J Douvier, and J Vergeret, and A Taytard, and E Brottier, and P Domblides, and F Dubos, and P Freour
January 1981, Lancet (London, England),
J J Douvier, and J Vergeret, and A Taytard, and E Brottier, and P Domblides, and F Dubos, and P Freour
February 1989, Archives of internal medicine,
J J Douvier, and J Vergeret, and A Taytard, and E Brottier, and P Domblides, and F Dubos, and P Freour
June 1978, Lancet (London, England),
J J Douvier, and J Vergeret, and A Taytard, and E Brottier, and P Domblides, and F Dubos, and P Freour
September 1978, Lancet (London, England),
J J Douvier, and J Vergeret, and A Taytard, and E Brottier, and P Domblides, and F Dubos, and P Freour
December 1978, British journal of hospital medicine,
J J Douvier, and J Vergeret, and A Taytard, and E Brottier, and P Domblides, and F Dubos, and P Freour
April 1986, Thorax,
J J Douvier, and J Vergeret, and A Taytard, and E Brottier, and P Domblides, and F Dubos, and P Freour
February 1981, Lancet (London, England),
J J Douvier, and J Vergeret, and A Taytard, and E Brottier, and P Domblides, and F Dubos, and P Freour
January 1986, Therapie,
Copied contents to your clipboard!